Optimizing Myelofibrosis Management: Clinical Strategies, Treatment Innovations, and Financial Toxicity Considerations : Episode 3

Impact of Myelofibrosis on Quality of Life: Key Clinical Features

August 7, 2024

By Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Opinion

Video

An expert on myelofibrosis provides clinical insights on features of the disease that can impact patient quality of life, including splenomegaly, hypertension, and bone pain.

EP: 1.Myelofibrosis Overview: US Incidence, Prognosis, and Patient Presentation

EP: 2.Unmet Needs in Myelofibrosis: Key Challenges in Disease Management

Now Viewing

EP: 3.Impact of Myelofibrosis on Quality of Life: Key Clinical Features

EP: 4.Primary Management Goals and Importance of Risk Stratification in Myelofibrosis

EP: 5.JAK Inhibitors and Myelofibrosis Management: A Review of Current Treatments

EP: 6.Key Patient Factors Guiding Myelofibrosis Treatment Selection

EP: 7.Key Outcomes for Monitoring Myelofibrosis Treatment Response

EP: 8.Strategies for Treatment Optimization and Adverse Event Reduction in Myelofibrosis

EP: 9.Understanding Financial Toxicity in Myelofibrosis

EP: 10.Advancing Myelofibrosis Treatment: What Lies Ahead

EP: 11.K-Cast Written Summary. Optimizing the Management of Myelofibrosis

Video content above is prompted by the following question:

What are some of the clinical features of the disease that impact greatest on patient quality of life?

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!